We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPRT:NASDAQOportun Financial Corporation Analysis

Data as of 2026-05-21 - not real-time

$5.41

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Oportun has delivered a sixth straight quarter of GAAP profitability and reinforced its balance sheet, supporting the recent positive earnings guidance. Technical momentum is neutral with the short‑term moving average modestly above the medium‑term average, while the relative strength index hovers around the midpoint, suggesting neither strong buying nor selling pressure. The MACD pattern has turned bearish and volume trends are decreasing, placing the stock near a key support level and below a clear resistance zone. Valuation metrics highlight a stark gap between market price and intrinsic value, with the discounted cash‑flow model indicating substantial upside. However, the stock exhibits a high beta and elevated 30‑day volatility, reflecting heightened market sensitivity and a sizable historical drawdown. Upcoming earnings and the rollout of risk‑based pricing in the second half of the year could act as catalysts for price movement.
Given the blend of solid fundamentals, strong cash generation, and a mission‑driven niche, the long‑term outlook remains favorable despite short‑term technical softness. The absence of a dividend and a capital‑intensive balance sheet temper expectations, but the low price‑to‑book and price‑to‑sales ratios reinforce a value‑oriented investment case. Market sentiment is currently in an “extreme greed” phase, which may provide additional short‑term momentum if earnings meet expectations. Overall, the company appears undervalued with upside potential, though investors should remain mindful of its volatility and sector‑specific credit risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical indicators show bearish MACD and falling volume
  • Price is near a defined support level
  • Upcoming earnings could confirm momentum direction

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount to DCF fair value
  • Consistent profitability and strong cash flow generation
  • Positive earnings guidance and risk‑based pricing rollout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Fundamentally undervalued with low price‑to‑book and price‑to‑sales ratios
  • Mission‑driven niche in credit services offering stable demand
  • Long‑term upside potential reflected in intrinsic value estimates

Key Metrics & Analysis

Financial Health

Revenue Growth1.30%
Profit Margin2.45%
P/E Ratio14.6
ROE4.68%
ROA0.56%
Debt/Equity685.78
P/B Ratio0.6
Op. Cash Flow$416.2M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI49.0
Support$5.10
Resistance$6.14
MA 20$5.61
MA 50$5.17
MA 200$5.46
MACDBearish
VolumeDecreasing
Fear & Greed Index91.27

Valuation

Fair Value$29.91
Target Price$8.50
Upside/Downside57.12%
GradeUndervalued
TypeValue

Risk Assessment

Beta2.12
Volatility55.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.